zepbound vs compound tirzepatide Compounded Zepbound: What You Need to Know Compounded Tirzepatide vs Zepbound: Side-by-Side

Participants receiving semaglutide 2.4 mg weekly lost significantly more weight than those on placebo, with benefits observed across age groups and BMI ranges

Semaglutide increases glucose-dependent insulin release, decreases glucagon secretion, and slows gastric emptying

However, emerging research suggests potential benefits for women with polycystic ovary syndrome (PCOS), a condition characterised by insulin resistance and multiple ovarian follicles

This allowed for assessment of the impact of long-term use, and contextualized use as compared to clinical trials

Diabetic dermopathy: A subtle sign with grave implications